일본과 해외의 조사회사나 출판사로부터 출판된 산업 조사 보고서 및 데이터 판매 · 연간 서비스 · 맞춤 정보 제공 ChosaReport-Korea 주식회사 SEMABIZ

디지털 약국 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤마켓츠)출판년월 : 2022년06월

디지털 약국 시장 : 의약품(Rx, OTC), 제품(의약품, 퍼스널 케어, 비타민 및 보충제, 당뇨병, CVD, 종양학), 플랫폼(앱, 웹사이트), 비즈니스 모델(캡티브, 프랜차이즈, 어그리게이터), 지리적(도시, 지방 ) – 2027년까지의 세계 예측
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

페이지수 218
도표수 211
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population.
However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period.
디지털 약국 시장은 예측 기간 동안 17.0%의 CAGR로 2022년 965억 달러에서 2027년 2,119억 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 COVID-19 팬데믹 기간 및 이후 온라인 의약품 구매에 대한 소비자 선호도 증가, 시장 및 파트너십의 통합, 노인 인구 증가에 의해 주도됩니다.
그러나 임상 지원을 약사에게 의존하는 환자와 불법 약국의 수가 증가함에 따라 예측 기간 동안 이 시장의 성장이 억제될 것으로 예상됩니다.

“Over-the-counter (OTC) productssegment isestimated to grow at the highest rate during the forecast period”
On the basis ofdrug type, the digital pharmacy market is segmented into prescription medicines and over-the-counter products. Prescription medicines accounted for the largest share of the global digital pharmacy market in 2021. The large share of this market segment can be attributed to factors such as growing prevalence of several chronic disorders and the subsequent growing demand for medications.
On the other hand, the over-the-counter (OTC) products segment isexpected to grow at the highest CAGR during the forecast period. Growth in this market segment is largely driven by the widespread availability and cost-effectiveness of over-the-counter products and the growing trend of self-medication.

“The Medicines & Treatmentssegment is expected to account for the largest share of theDigital Pharmacymarket in 2021”

On the basis ofproducts, the digital pharmacy market is segmented into medicines & treatments, personal care products, vitamins & supplements, and other products. The medicines & treatments segment accounted for the largest share of the global digital pharmacy market in 2021.
However, the vitamins & supplements segment is expected to register the highest CAGR during the forecast period due to increase prevalence of chronic diseases and the availability of multiple product options.

“Appssegment in the platformis expected to account for the largest share of the global digital pharmacy market”
On the basis ofplatforms, the digital pharmacy market is segmented into apps and websites. In 2021, apps is expected to hold the largest share of the global digital pharmacy market, growth in this segment is attributed to factors as the appsoffer lucrative promos or discounts to attract customers.The websitesplatform is estimated to grow at the second-highest CAGR during the forecast period due to convenience, privacy, and safety offered by websites are key factors driving the market growth.

“Captive segmentamong the business model accounted for the largest share of the global digital pharmacy market in 2021”

On the basis ofbusiness models, the digital pharmacy market is segmented into captive, franchise, and aggregator business models. The captive business model accounted for the largest share of the global digital pharmacy market in 2021 The captive business model is also estimated to register the highest CAGR during the forecast period. The flexibility, accessibility, and affordability of captive business models are key factors to segmental growth in the digital pharmacy market. The aggregator business model is estimated to grow at the second-highest CAGR during the forecast period.

“The Urbanareasaccounted for the largest share of the global digital pharmacy market in 2021”

On the basis ofgeographic coverage, the digital pharmacy market is segmented into urban and rural areas. Urban areas accounted for the largest share of the global digital pharmacy market in 2021 due to the growing penetration of the internet in urban areas.

“North America todominate the digital pharmacy market during forecast period”

North America accounted for the largest share of the digital pharmacy market in 2022. The growing prevalence of chronic conditions, the rising number of drug prescriptions resulting from the rapidly growing aging population, and the presence of key market players in the region are the key factors driving the growth of the digital pharmacy market in North America.
The Asia Pacific market is projected to register the highest CAGR during the forecast period, owing to the growing disease burden, growing patient population, and the rapidly growing pharmaceutical market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (41%), Tier 2(31%), and Tier 3 (28%)
• By Designation: C-level (44%), Director-level (35%), and Others (21%)
• By Region: North America (46%), Europe (26%), Asia Pacific(18%),Latin America (7%) and Middle East & Africa (3%)

Prominent players in this market are CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreens Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims& Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), RO Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada).These players are increasingly focusing on product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations to expand their product offerings in the digital pharmacy market.

Research Coverage
• The report studies theDigital Pharmacymarket based on drug type, products,platform,business model,geographic coverage, and region
• The report analyzes factors (such as drivers, restraints, opportunities, andchallenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total digital pharmacy market
• The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Digital Pharmacy market and provides them information on key market drivers, restraints, challenges, and opportunities.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 DIGITAL PHARMACY MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.5.1 SCOPE-RELATED LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 30)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION
2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH
2.2.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
FIGURE 7 DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH
2.2.4 GROWTH FORECAST
FIGURE 8 IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
2.5 LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: DIGITAL PHARMACY MARKET

3 EXECUTIVE SUMMARY (Page No. – 43)
FIGURE 11 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 DIGITAL PHARMACY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 DIGITAL PHARMACY MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION)
FIGURE 14 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2022 VS. 2027 (USD MILLION)
FIGURE 15 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET

4 PREMIUM INSIGHTS (Page No. – 48)
4.1 DIGITAL PHARMACY MARKET OVERVIEW
FIGURE 17 GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH
4.2 DIGITAL PHARMACY MARKET, BY PRODUCT
FIGURE 18 MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PHARMACY MARKET IN 2021
4.3 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG & COUNTRY (2021)
FIGURE 19 PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
4.4 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET
FIGURE 20 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
4.5 MARKET DYNAMICS
FIGURE 21 DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
4.5.1 DRIVERS
4.5.1.1 Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic
TABLE 2 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022)
4.5.1.2 Consolidation in the market and partnerships
4.5.1.3 Growing geriatric population
TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)
4.5.2 RESTRAINTS
4.5.2.1 Growing number of illegal pharmacies
4.5.2.2 Risk of counterfeit drugs
4.5.2.3 Increased risk of drug abuse
4.5.3 OPPORTUNITIES
4.5.3.1 Emerging markets
4.5.3.2 Benefits of E-commerce
4.5.4 CHALLENGES
4.5.4.1 Challenges for patients relying on pharmacists for clinical support
4.5.4.2 Lack of strong national laws worldwide
4.5.4.3 Security and privacy concerns
4.6 VALUE CHAIN ANALYSIS
4.7 ECOSYSTEM ANALYSIS
4.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 DIGITAL PHARMACY MARKET: PORTER’S FIVE FORCES ANALYSIS
4.8.1 INTENSITY OF COMPETITIVE RIVALRY
4.8.2 BARGAINING POWER OF SUPPLIERS
4.8.3 BARGAINING POWER OF BUYERS
4.8.4 THREAT FROM SUBSTITUTES
4.8.5 THREAT FROM NEW ENTRANTS
4.9 PRICING & REIMBURSEMENT ANALYSIS
5 COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS
4.10 TECHNOLOGY ANALYSIS
4.10.1 MACHINE LEARNING
4.10.2 INTERNET OF THINGS
4.10.3 BLOCKCHAIN
4.10.4 CLOUD COMPUTING
4.11 INDUSTRY TRENDS
4.11.1 ONLINE PRESCRIPTION REFILL
4.11.2 VIRTUAL HEALTHCARE SERVICES
4.11.3 DIGITAL HEALTH DIAGNOSTIC TOOLS
4.12 KEY CONFERENCES & EVENTS IN 2021–2022
4.13 REGULATORY ANALYSIS
4.13.1 NORTH AMERICA
4.13.1.1 US
4.13.1.2 Canada
4.13.2 EUROPE
4.13.3 ASIA PACIFIC
4.13.4 REST OF THE WORLD
TABLE 6 APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE TO CONTROL MEDICINAL PRODUCT ONLINE SALES
4.14 CASE STUDIES
4.14.1 MAGENTO 2 WEB APP MODERNIZATION
4.14.1.1 Use Case 1: Need to Revamp Online Store
4.14.2 WALMART REACT NATIVE PHARMACY
4.14.2.1 Use Case 2: Need to Rebuild Pharmacy App
4.15 IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET

5 DIGITAL PHARMACY MARKET, BY DRUG TYPE (Page No. – 70)
5.1 INTRODUCTION
TABLE 7 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
5.2 PRESCRIPTION MEDICINES
5.2.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION
TABLE 8 DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 10 EUROPE: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION)
5.3 OVER-THE-COUNTER PRODUCTS
5.3.1 EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH
TABLE 11 DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 12 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 13 EUROPE: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)

6 DIGITAL PHARMACY MARKET, BY PRODUCT (Page No. – 76)
6.1 INTRODUCTION
TABLE 14 DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 MEDICINES & TREATMENTS
TABLE 15 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 16 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 18 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 DIABETES CARE
6.2.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
TABLE 20 DIGITAL PHARMACY MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
6.2.2 HEART CARE
6.2.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
TABLE 21 DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
6.2.3 ONCOLOGY
6.2.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
TABLE 22 DIGITAL PHARMACY MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
6.2.3.2 Other medicines & treatments
TABLE 23 DIGITAL PHARMACY MARKET FOR OTHER MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
6.3 PERSONAL CARE PRODUCTS
6.3.1 GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH
TABLE 24 DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 25 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 EUROPE: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 VITAMINS & SUPPLEMENTS
6.4.1 GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH
TABLE 28 DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 EUROPE: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 OTHER PRODUCTS
TABLE 32 DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 33 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 34 EUROPE: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)

7 DIGITAL PHARMACY MARKET, BY PLATFORM (Page No. – 88)
7.1 INTRODUCTION
TABLE 36 DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
7.2 APPS
7.2.1 ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL DRIVE THE DEMAND FOR APPS
TABLE 37 DIGITAL PHARMACY APPS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 WEBSITES
7.3.1 PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH
TABLE 41 DIGITAL PHARMACY WEBSITES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL (Page No. – 94)
8.1 INTRODUCTION
TABLE 45 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
8.2 CAPTIVE
8.2.1 FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS—KEY FACTORS DRIVING MARKET GROWTH
TABLE 46 DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY REGION, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 EUROPE: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 49 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 FRANCHISE
8.3.1 GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH
TABLE 50 DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY REGION, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 EUROPE: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 AGGREGATOR
8.4.1 QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH
TABLE 54 DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY REGION, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)

9 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE (Page No. – 102)
9.1 INTRODUCTION
ABLE 58 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
9.2 URBAN AREAS
9.2.1 RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT
TABLE 59 DIGITAL PHARMACY MARKET IN URBAN AREAS, BY REGION, 2020–2027 (USD MILLION)
9.3 RURAL AREAS
9.3.1 GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS
TABLE 60 DIGITAL PHARMACY MARKET IN RURAL AREAS, BY REGION, 2020–2027 (USD MILLION)

10 DIGITAL PHARMACY MARKET, BY REGION (Page No. – 106)
10.1 INTRODUCTION
TABLE 61 DIGITAL PHARMACY MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 IMPACT OF COVID-19 ON THE NORTH AMERICAN DIGITAL PHARMACY MARKET
FIGURE 22 NORTH AMERICA: DIGITAL PHARMACY MARKET SNAPSHOT
TABLE 62 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
10.2.2 US
10.2.2.1 The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions
TABLE 69 US: KEY MACROINDICATORS
TABLE 70 US: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 71 US: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 72 US: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 US: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 74 US: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
TABLE 75 US: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising drug expenditures to propel market growth in Canada
TABLE 76 CANADA: KEY MACROINDICATORS
TABLE 77 CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 78 CANADA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 79 CANADA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 CANADA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 81 CANADA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
TABLE 82 CANADA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
10.3 EUROPE
10.3.1 IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET
TABLE 83 EUROPE: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 85 EUROPE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 86 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: DIGITAL PHARMACY MARKET, BY PLATFORM,  2020–2027 (USD MILLION)
TABLE 88 EUROPE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Germany is the fastest-growing market for digital pharmacies in Europe
TABLE 89 GERMANY: KEY MACROINDICATORS
TABLE 90 GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 91 GERMANY: DIGITAL PHARMACY MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
TABLE 92 GERMANY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 GERMANY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 94 GERMANY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising initiatives to improve the safety of digital pharmacies to boost the market growth
TABLE 95 UK: KEY MACROINDICATORS
TABLE 96 UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 97 UK: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 98 UK: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 UK: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 100 UK: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Rising geriatric population in the country to support market growth
TABLE 101 FRANCE: KEY MACROINDICATORS
TABLE 102 FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 103 FRANCE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 104 FRANCE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 FRANCE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 106 FRANCE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Growing burden of chronic diseases is driving the market growth in Italy
TABLE 107 ITALY: KEY MACROINDICATORS
TABLE 108 ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 109 ITALY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 110 ITALY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 ITALY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 112 ITALY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Increasing focus on improving the healthcare infrastructure in the country to support market growth
TABLE 113 SPAIN: KEY MACROINDICATORS
TABLE 114 SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 115 SPAIN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 SPAIN: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 SPAIN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 118 SPAIN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.3.7 ROE
TABLE 119 ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 120 ROE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 ROE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 ROE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 123 ROE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET
FIGURE 23 ASIA PACIFIC: DIGITAL PHARMACY MARKET SNAPSHOT
TABLE 124 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 126 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing consumer demand for OTC products to drive the market for digital pharmacy in China
TABLE 128 CHINA: KEY MACROINDICATORS
TABLE 129 CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 130 CHINA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 131 CHINA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan
TABLE 132 JAPAN: KEY MACROINDICATORS
TABLE 133 JAPAN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 135 JAPAN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Favorable government initiatives and high density of rural population to support market growth in India
TABLE 136 INDIA: KEY MACROINDICATORS
TABLE 137 INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 138 INDIA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 139 INDIA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 INDIA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 141 INDIA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 142 ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 143 ROAPAC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 ROAPAC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 145 ROAPAC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM
10.5.1.1 Impact of COVID-19 on the Latin American digital pharmacy market
TABLE 146 LATIN AMERICA: KEY MACROINDICATORS
TABLE 147 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 148 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 149 LATIN AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 151 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA
10.6.1.1 Impact of COVID-19 on the Middle East & Africa digital pharmacy market
TABLE 152 MEA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
TABLE 153 MEA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 154 MEA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 MEA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
TABLE 156 MEA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. – 154)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PHARMACY MARKET
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
11.4 MARKET RANKING
FIGURE 24 US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021
11.5 COMPETITIVE BENCHMARKING
11.5.1 OVERALL COMPANY FOOTPRINT
TABLE 157 OVERALL COMPANY FOOTPRINT
11.5.2 COMPANY DRUG TYPE FOOTPRINT
TABLE 158 COMPANY DRUG TYPE FOOTPRINT
11.5.3 COMPANY PRODUCT FOOTPRINT
TABLE 159 COMPANY PRODUCT FOOTPRINT
11.5.4 COMPANY PLATFORM FOOTPRINT
TABLE 160 COMPANY PLATFORM FOOTPRINT
11.5.5 COMPANY REGIONAL FOOTPRINT
TABLE 161 COMPANY REGIONAL FOOTPRINT
TABLE 162 DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES
11.6 COMPETITIVE LEADERSHIP MAPPING
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 25 DIGITAL PHARMACY MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
11.7 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 26 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET
11.8 COMPETITIVE SITUATIONS AND TRENDS
11.8.1 PRODUCT/SERVICE UPGRADES
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. – 167)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 CVS HEALTH
TABLE 163 CVS HEALTH: BUSINESS OVERVIEW
FIGURE 27 CVS HEALTH: COMPANY SNAPSHOT (2021)
12.1.2 CIGNA
TABLE 164 CIGNA: BUSINESS OVERVIEW
FIGURE 28 CIGNA: COMPANY SNAPSHOT (2021)
12.1.3 OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP)
TABLE 165 OPTUM, INC.: BUSINESS OVERVIEW
FIGURE 29 OPTUM, INC.: COMPANY SNAPSHOT (2021)
12.1.4 WALGREEN CO.
TABLE 166 WALGREEN CO.: BUSINESS OVERVIEW
FIGURE 30 WALGREEN CO.: COMPANY SNAPSHOT (2021)
12.1.5 WALMART INC.
TABLE 167 WALMART INC.: BUSINESS OVERVIEW
FIGURE 31 WALMART INC.: COMPANY SNAPSHOT (2021)
12.1.6 THE KROGER CO.
TABLE 168 THE KROGER CO.: BUSINESS OVERVIEW
FIGURE 32 THE KROGER CO.: COMPANY SNAPSHOT (2020)
12.1.7 GIANT EAGLE, INC.
TABLE 169 GIANT EAGLE, INC.: BUSINESS OVERVIEW
12.1.8 AMAZON.COM, INC.
TABLE 170 AMAZON.COM, INC.: BUSINESS OVERVIEW
FIGURE 33 AMAZON.COM, INC.: COMPANY SNAPSHOT (2020)
12.1.9 PHARMEASY
TABLE 171 PHARMEASY: BUSINESS OVERVIEW
12.1.10 APEX PHARMACY
TABLE 172 APEX PHARMACY: BUSINESS OVERVIEW
12.1.11 APOLLO PHARMACY
TABLE 173 APOLLO PHARMACY: BUSINESS OVERVIEW
FIGURE 34 APOLLO HOSPITAL: COMPANY SNAPSHOT (2021)
12.1.12 RITE AID CORP
TABLE 174 RITE AID CORP.: BUSINESS OVERVIEW
FIGURE 35 RITE AID CORP.: COMPANY SNAPSHOT (2021)
12.1.13 COSTCO WHOLESALE CORPORATION
TABLE 175 COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW
FIGURE 36 COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021)
12.2 SHOP-APOTHEKE.COM
12.2.1 NETMEDS.COM
12.2.2 DOCMORRIS
12.2.3 TATA 1MG
12.2.4 LLOYDSPHARMACY
12.2.5 GOODRX, INC.
12.2.6 HEALTHWAREHOUSE.COM
12.2.7 TELUS HEALTH
12.2.8 PHARMEX DIRECT INC.
12.2.9 HIMS & HERS HEALTH, INC.
12.2.10 RO PHARMACY
12.2.11 RX OUTREACH
12.2.12 THE INDEPENDENT PHARMACY
12.2.13 REXALL PHARMACY GROUP ULC
12.2.14 NORTHWESTPHARMACY.COM

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. – 217)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS


    주문/문의폼

    • 리포트 제목은 자동으로 입력됩니다.

    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com